Extramammary/vulvar Paget disease | Pagetoid urothelial carcinoma | Pagetoid colorectal carcinoma | High-risk HPV-associated neoplasm | |
---|---|---|---|---|
History | Not characterized | Prior urinary tract neoplasm | Prior anorectal neoplasm | Atypical squamous/glandular cells in screening cytology |
Cell morphology | Paget cells characterized by abundant pale cytoplasm and prominent nucleoli with rare mitoses | Highly stratified/disarranged or pleomorphic/anaplastic cells with mitotic activity | Colonic type cells with intracytoplasmic mucin and goblet cells | Cells indicating high-grade squamous/glandular intraepithelial lesion or their invasive forms |
Immunochemical markers | ||||
Typically positive | CK7, CAM5.2, GCDFP15, CEA, CA125, HER2/neu, androgen receptor | CKs 7 and 20 (co-expression), p63, HMWCK, uroplakins II and III, thrombomodulin | CK20, CEA, CDX2, MUC2 | p40, p63, HMWCK (squamous neoplasm); CK7, CEA (glandular neoplasm) |
Typically negative | CK20, ER, PgR | GCDFP15, CEA | CK7, GCDFP15 | CK20, GCDFP15 |
p16/Ki-67 double labeling | Unknown | Usually positiveRef #9 | Unknown | Positive |
GATA3 | PositiveRef #10 | Usually positiveRef #11 | NegativeRef #11 | Usually negative, but occasionally weakly positiveRef #12 |
HPV test | Negative | Negative | Negative | High-risk genotypes detected |